Literature DB >> 22308546

Changes in the key areas of quality of life associated with age and time since diagnosis of long-term conditions.

Lisa A Osborne1, Neil Bindemann, J Gareth Noble, Phil Reed.   

Abstract

This study examined whether quality of life areas, that were considered to be important by people with long-term and chronic conditions, altered as a function of their age ('maturational') and time since diagnosis ('adaptational'). Seventy-one individuals from two age groups (31-40 and 41-50 years), who had been diagnosed for different lengths of time (<1 year and 10-20 years), creating four groups, were asked to say what quality of life meant to them, and the results were qualitatively analysed. The key theme in determining the quality of life across the entire sample was 'independence and normality' in the participants' lives. However, the other key themes differed across the groups, suggesting that both 'maturation' and 'adaptation' play a role in determining the key areas that people consider, relating to their quality of life. The younger newly diagnosed group made more mention of 'involvement' than the other three groups, all of which mentioned different forms of wellbeing (social-emotional, physical and psychological) as the second most important aspect of their quality of life. These findings have implications for the assessment of quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22308546     DOI: 10.1177/1742395312436747

Source DB:  PubMed          Journal:  Chronic Illn        ISSN: 1742-3953


  2 in total

1.  The impact of urinary stone disease and their treatment on patients' quality of life: a qualitative study.

Authors:  Aditya Raja; Fiona Wood; Hrishi B Joshi
Journal:  Urolithiasis       Date:  2019-06-25       Impact factor: 3.436

2.  How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS register.

Authors:  Kerina H Jones; David V Ford; Philip A Jones; Ann John; Rodden M Middleton; Hazel Lockhart-Jones; Jeffrey Peng; Lisa A Osborne; J Gareth Noble
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.